Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity

Archives of Ophthalmology

Volumn 124, Issue 12, 2006, Pages 1711-1718

  Löfqvist, Chatarina ^a,b   Andersson, Eva ^a   Sigurdsson, Jon ^a   Engström, Eva ^a   Hård, Anna Lena ^a   Niklasson, Aimon ^a   Smith, Lois E H ^b   Hellström, Ann ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ALGORITHM; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; MALE; NEWBORN; POSTNATAL GROWTH; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; SCREENING; WEIGHT GAIN;

ALGORITHMS; BIOLOGICAL MARKERS; BIRTH WEIGHT; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; RADIOIMMUNOASSAY; REFERENCE VALUES; RETINOPATHY OF PREMATURITY; RISK FACTORS; WEIGHT GAIN;

EID: 33845495388     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.12.1711     Document Type: Article

References (21)

1. Flynn JT. An International Classification of Retinopathy of Prematurity: development of the classification of the late stages of retinopathy of prematurity. Birth Defects Orig Artic Ser. 1988;24:175-183, C2-C3.
2. Holmstrom G, el Azazi M, Jacobson L, Lennerstrand G. A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. Br J Ophthalmol. 1993;77:417-423.
3. Ng YK, Fielder AR, Shaw DE, Levene MI. Epidemiology of retinopathy of prematurity. Lancet. 1988;2:1235-1238.
4. Hellstrom A, Engstrom E, Hard AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003;112:1016-1020.
5. Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul. 1994;4(suppl 1):11-19.
6. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102:1130-1134.
7. Frisén M. Statistical surveillance: optimality and methods. Int Stat Rev. 2003;71:403-434.
8. Shiryaev AN. On optimum methods in quickest detection problems. Theory Probab Appl. 1963;8:22-46.
9. Roberts SW. A comparison of some control chart procedures. Technometrics. 1966;8:411-430.
10. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Pediatrics. 1988;81:697-706.
11. Fledelius HC, Rosenberg T. Retinopathy of prematurity: where to set screening limits? recommendations based on two Danish surveys. Acta Paediatr Scand. 1990;79:906-910.
12. Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity. Br J Ophthalmol. 1996;80:425-428.
13. Clarke WN, Hodges E, Noel LP, Roberts D, Coneys M. The oculocardiac reflex during ophthalmoscopy in premature infants. Am J Ophthalmol. 1985;99:649-651.
14. Hubler A, Knote K, Kauf E, Barz D, Schlenvoigt D, Schramm D. Does insulin-like growth factor 1 contribute in red blood cell transfusions to the pathogenesis of retinopathy of prematurity during retinal neovascularization? Biol Neonate. 2006;89:92-98.
15. Villegas Becerril E, Gonzalez Fernandez R, Fernandez Molina F, Gallardo Galera JM. Growth factor levels and ROP. Ophthalmology. 2005;112:2238.
16. Villegas Becerril E, Fernandez Molina F, Gonzalez R, Gallardo Galera JM. Serum IGF-I levels in retinopathy of prematurity: new indications for ROP screening [in Spanish]. Arch Soc Esp Oftalmol. 2005;80:233-238.
17. Wallace DK, Kylstra JA, Phillips SJ, Hall JG. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J AAPOS. 2000;4:343-347.
18. Allegaert K, Vanhole C, Casteels I, et al. Perinatal growth characteristics and associated risk of developing threshold retinopathy of prematurity. J AAPOS. 2003;7:34-37.
19. Ranke MB, Osterziel KJ, Schweizer R, et al. Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clin Chem Lab Med. 2003;41:1329-1334.
20. Landin-Wilhelmsen K, Lundberg PA, Lappas G, Wilhelmsen L. Insulin-like growth factor I levels in healthy adults. Horm Res. 2004;62(suppl 1):8-16.
21. Rinaldi S, Toniolo P, Muti P, et al. IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev. 2005;14:493-496.